Characterization and Quality Control of Autologous Gene Transfer Therapeutics

Lotze M.T. ; Finn O.J. Recent advances in cellular immunology: Implications for immunity to cancer. Immunol. Today 11: 190193; 1990.

Fearon E.R. ; Pardoll D.M. ; Itaya T. ; Golumbek P. ; Levitsky H.I. ; Simons J.W. ; Karasuyama H. ; Vogelstein B. ; Frost P. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60: 397403; 1990.

Perrillo R.P. ; Schiff E.R. ; Davis G.L. ; Bodenheimer H.C. Jr. ; Lindsay K. ; Payne J. ; Dienstag J.L. ; O'Brien C. ; Tamburro C. ; Jacobson I.M. ; Sampliner R. ; Feit D. ; Lefkowitch J. ; Kuhns M. ; Meschievitz C. ; Sanghvi B. ; Albrecht J. ; Gibas A. ; Hepatitis Interventional Therapy Group. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N. Engl. J. Med. 323: 295301; 1990.

Davis G.L. ; Balart L.A. ; Schiff E.R. ; Lindsay K. ; Bodenheimer H.C. Jr. ; Perrillo R.P. ; Carey W. ; Jacobson I.M. ; Payne J. ; Dienstag J.L. ; VanThiel D.H. ; Tamburro C. ; Lefkowitch J. ; Albrecht J. ; Meschievitz C. ; Ortego T.J. ; Gibas A. ; Hepatitis Interventional Therapy Group. Treatment of chronic hepatitis C with recombinant interferon alfa. N. Engl. J. of Med. 321: 15011510; 1989.

Morton D.L. ; Foshag L.J. ; Hoon D.S.B. ; Nizze J.A. ; Wanek L.A. ; Chang C. ; Davtyan D.G. ; Gupta R.K. ; Elashoff R. ; Irie R.F. Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine. Ann. Surg. 216: 463482; 1992.

Miller A.D. Retrovirus packing cells. Hum. Gene Ther. 1: 514; 1990.

Howard B. ; Burrascano M. ; McCallister T. ; Chong K. ; Gangavalli R. ; Jolly D.J. ; Darrow T. ; Vervaert C. ; Wahab Z. ; Seigler H.F. ; Barber J.R. Retroviral-mediated gene transfer of the human γ-IFN gene: A therapy for cancer. Ann. N.Y. Acad. Sci. (in press).

Chada S. ; DeJesus C.E. ; Townsend K. ; Lee W.T.L. ; Laube L. ; Jolly D.J. ; Chang S.M.W. ; Warner J.F. Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes. J. Virol. 67: 34093417; 1993.

Watanabe Y. Transfection of interferon-γ gene in animal tumors — model for local cytokine production and tumor immunity. Semin. Cancer Biol. 3: 4346; 1992.

The FDA Points to Consider for Somatic Cell and Gene Therapy, Cell Lines Used to Produce Biologicals, Biologicals Produced by Recombinant DNA Technology and Administration of Activated Leukocytes, can be obtained from the Biologics Information Staff, Office of the Director, Center for Biologies, FDA, Bethesda, MD 20205, USA.

Lander M.R. ; Chattopadhyay S.K. A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ecotropic, amphotropic, xenotropic, and mink cell focus-forming viruses. J. Virol. 52: 695698; 1984.